1. Home
  2. ZDGE vs VERU Comparison

ZDGE vs VERU Comparison

Compare ZDGE & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zedge Inc. Class B

ZDGE

Zedge Inc. Class B

HOLD

Current Price

$3.01

Market Cap

38.9M

Sector

Technology

ML Signal

HOLD

Logo Veru Inc.

VERU

Veru Inc.

N/A

Current Price

$2.34

Market Cap

44.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ZDGE
VERU
Founded
2008
1971
Country
United States
United States
Employees
55
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.9M
44.0M
IPO Year
2016
1996

Fundamental Metrics

Financial Performance
Metric
ZDGE
VERU
Price
$3.01
$2.34
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$22.50
AVG Volume (30 Days)
65.7K
202.3K
Earning Date
06-11-2026
05-12-2026
Dividend Yield
1.96%
N/A
EPS Growth
73.85
N/A
EPS
N/A
N/A
Revenue
$29,398,000.00
$16,296,958.00
Revenue This Year
$3.27
N/A
Revenue Next Year
$5.78
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.21
$2.05
52 Week High
$4.70
$7.33

Technical Indicators

Market Signals
Indicator
ZDGE
VERU
Relative Strength Index (RSI) 49.21 36.57
Support Level $2.88 $2.12
Resistance Level $3.15 $2.40
Average True Range (ATR) 0.13 0.13
MACD 0.01 -0.05
Stochastic Oscillator 37.93 1.79

Price Performance

Historical Comparison
ZDGE
VERU

About ZDGE Zedge Inc. Class B

Zedge Inc builds digital marketplaces and competitive games centered on content that people use for self-expression. Its products include the Zedge App, a freemium digital content marketplace offering mobile wallpapers, video wallpapers, ringtones, and notification sounds, along with pAInt, a generative AI wallpaper and ringtone maker, GuruShots, a skill-based photo challenge game, and Emojipedia, a trusted source for emoji information. The Zedge App is available on Google Play and the App Store. The company operates two segments: Zedge Marketplace and GuruShots, with the majority of revenue generated from the Zedge Marketplace.

About VERU Veru Inc.

Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.

Share on Social Networks: